6.48
0.21 (3.27%)
| Penutupan Terdahulu | 6.27 |
| Buka | 6.23 |
| Jumlah Dagangan | 1,920,072 |
| Purata Dagangan (3B) | 4,672,551 |
| Modal Pasaran | 2,308,408,576 |
| Harga / Pendapatan (P/E Ke hadapan) | 270.27 |
| Harga / Jualan (P/S) | 56.39 |
| Harga / Buku (P/B) | 95.67 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Aug 2026 |
| Margin Operasi (TTM) | -1,685.01% |
| EPS Cair (TTM) | -0.550 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 25.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 35.04% |
| Nisbah Semasa (MRQ) | 3.53 |
| Aliran Tunai Operasi (OCF TTM) | -70.41 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -53.20 M |
| Pulangan Atas Aset (ROA TTM) | -44.04% |
| Pulangan Atas Ekuiti (ROE TTM) | -278.55% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Precigen, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -4.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | -0.75 |
|
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 10.56% |
| % Dimiliki oleh Institusi | 67.08% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Patient Capital Management, Llc | 31 Mar 2026 | 17,817,387 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| THOMASIAN HARRY JR. | - | 6.27 | -100,000 | -627,000 |
| Jumlah Keseluruhan Kuantiti Bersih | -100,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -627,000 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 6.27 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| THOMASIAN HARRY JR. | Pegawai | 31 Jul 2026 | Jual automatik (-) | 100,000 | 6.27 | 627,000 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |